The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.
210 articles
Bladen County secures $26.6 million from DuPont and Chemours to upgrade water infrastructure following a PFAS pollution settlement tied to their Fayetteville Works plant, part of a larger $590 million
Chemours reported mixed Q2 results with trimmed net losses and improved cash flow despite flat net sales due to volume declines. Future performance hinges on pricing gains offsetting shrinking demand
Chemours, DuPont, and Corteva agreed to a $455 million settlement to resolve PFAS litigation concerning historical discharges from North Carolina's Fayetteville Works plant. The companies will split t
Chemours agreed to pay $455 million over 15 years to settle PFAS contamination claims at its Fayetteville Works plant. The settlement includes a $135 million reserve fund from DuPont to ensure payment
North Carolina secured a $590 million agreement from Chemours, DuPont, and Corteva for PFAS pollution cleanup and drinking water protection. The settlement allocates $455 million in damages and a $135
Chemours has reached a nearly $600 million settlement with North Carolina to provide clean drinking water for PFAS contamination. Backed by DuPont, the agreement ensures funds for local governments de
North Carolina officials announced a $590 million settlement with Chemours and DuPont regarding PFAS contamination. The agreement allocates $455 million to state and local governments, including Wilmi
A federal judge ruled Chemours and DuPont liable for PFAS contamination affecting over 180,000 North Carolina properties from their Fayetteville Works plant. A jury trial is scheduled for March 2027 t
Chemours agreed to a $450 million settlement addressing PFAS contamination at its Parkersburg facility amid Clean Water Act violations. Local residents question the adequacy of the remedy, citing long
Chemours has launched two new refrigerants, Opteon ZE and Opteon 515B, targeting the increasing cooling demands of AI-powered data centers. The company aims to position itself as a key player in AI in
A federal judge ruled Chemours liable for illegally dumping forever chemicals into the Cape Fear River since 1980, impacting over 180,000 residents. A jury trial is set for next March to determine com
AI data center expansion drives demand for PFAS-based cooling chemicals like Chemours' Opteon 2P50, sparking environmental concerns over contamination. Regulators face challenges monitoring impacts as
Chemours released its 2025 Sustainability Report, highlighting an 80% reduction in fluorinated organic chemical emissions and a 57% cut in greenhouse gases since 2018. The company also reported zero m
Chemours released its 2025 Sustainability Report confirming zero Tier 1 process safety events and distribution incidents. The report also highlighted an 80% reduction in fluorinated organic chemical e
Chemours released its 2025 Sustainability Report, detailing an 80% reduction in fluorinated organic chemical emissions and 57% cut in Scope 1 and 2 greenhouse gas emissions since 2018. The company rep
Chemours introduced two new low-global-warming-potential refrigerants for data center cooling, driving a 28% year-to-date stock gain despite PFAS litigation risks.
Chemours unveiled two new low global warming potential refrigerants for data center cooling, boosting stock value despite PFAS litigation risks. Analysts cite strong demand for the Opteon franchise as
Clean Cape Fear co-founders criticize Senate candidate Michael Whatley for accepting Chemours donations, citing his failure to support PFAS regulations and delays in pollution cleanup funding.
Chemours has launched two new low-GWP Opteon refrigerants, Opteon ZE and Opteon 515B, targeting supermarket chillers and commercial cooling applications. These products aim to aid regulatory complianc
Chemours Co President Michael Foley acquired nearly $30,000 in company stock following a Q2 earnings miss and UBS downgrade tied to refrigerant concerns. The purchase follows a 22% drop over six month
Chemours President Joseph T. Martinko purchased approximately $30,000 in shares following mixed Q2 results and a refrigerant business downgrade. Analysts predict a return to profitability despite rece
Chemours launched new low-GWP Opteon refrigerants for AI data centers, though investors remain cautious due to ongoing losses, PFAS liabilities, and a revised 2026 net loss outlook.
Chemours shares rose 5.4% despite three Wall Street firms cutting price targets, with JP Morgan maintaining a Neutral rating. Investors appear to have factored in the downward revisions or see potenti
BMO Capital analysts maintained Buy ratings for Chemours and West Fraser Timber, while issuing a Hold rating for Pan American Silver with respective price targets of $18, C$75, and $90.
Chemours President Gerardo Familiar purchased $30,050 worth of company shares following a recent 25% stock decline. The move comes amidst mixed Q2 results and analyst concerns regarding the refrigeran
Chemours Co President Gerardo Familiar Calderon purchased 1,935 shares at $15.53 per share on August 12, 2026, increasing his total holdings to 58,547 shares. The open-market transaction was not execu
Chemours Co's Chief Accounting Officer David Will withheld 2,426 shares to cover taxes on RSU vesting at $15.24 per share, leaving total holdings at 30,868 shares.
Zacks Research downgraded Chemours to 'Strong Sell' following missed quarterly earnings estimates for EPS and revenue. Analyst consensus remains Hold with a $21 price target despite the recent downgra
North Carolina officials oppose an EPA-Chemours PFAS settlement, citing insufficient state consultation and inadequate environmental remediation. Leaders urge a federal court to reject the deal to ens
Chemours Co director Mary B. Cranston purchased 6,000 shares at $15.825 per share on August 7, 2026, increasing her beneficial ownership to over 113,000 shares according to an SEC Form 4 filing.
ChemBrief